leadf
logo-loader
viewbit bio

Elpis Biomed thrilled to be crowned 'Start-up Of The Year' at tech awards

Elpis Biomed's Dr Mark Kotter spoke to Proactive London's Andrew Scott after being voted the 2018 Cambridge Start-Up of the Year.

Elpis is developing high quality human cells via its proprietary OPTi-OX platform.

Kotter also discusses their fundraise which they're in the middle of. He says he's looking to raise up to £5mln and is keen to expand the investor portfolio.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of bit bio named herein, including the promotion by the Company of bit bio in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Elpis BioMed applying its 'disruptive' technology to produce human cells at...

Mark Kotter, founder of Elpis BioMed Ltd, tells Proactive the company was spun-out of Cambridge University and is built around technology which allows you to produce human cells at scale. ''These are very important in the context of drug discovery, biomedical research and also cell...

on 27/7/18

2 min read